Effect of Oral and Injectable Risperidone on Prolactin in Psychotic Patients
Phase 3
Recruiting
- Conditions
- The effect of oral and injectable risperidone on serum prolactin level.
- Registration Number
- IRCT20221003056082N1
- Lead Sponsor
- niversity of social welfare and rehabilitation sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age 18 to 60 years
Having a psychotic disorder
No mood disorder
A candidate for antipsychotics
Not using antipsychotic drugs in the last year
Patient satisfaction and cooperation
Exclusion Criteria
Patients with high prolactin levels
Patients with hypothyroidism
Patients with impaired liver or kidney tests
Pregnant women
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum prolactin level. Timepoint: Before starting the treatment and on the first day, the seventh day and the fourteenth day after starting the treatment with oral or injectable risperidone. Method of measurement: Prolactin laboratory kit.
- Secondary Outcome Measures
Name Time Method Fasting blood sugar. Timepoint: Before the intervention and on the fourteenth day after the intervention. Method of measurement: Blood sugar laboratory kit.;Blood triglycerides. Timepoint: Before the intervention and on the fourteenth day after the intervention. Method of measurement: Triglyceride laboratory kit.;Blood cholesterol. Timepoint: Before the intervention and on the fourteenth day after the intervention. Method of measurement: Cholesterol laboratory kit.